Strong intracellular and negative peripheral expression of fibronectin in tumor cells contribute to invasion and metastasis in papillary thyroid carcinoma

Cancer Letters

Volumn 146, Issue 1, 1999, Pages 103-109

  Ryu, Shinso ^a   Jimi, Shiro ^a   Eura, Youichi ^a   Kato, Toshihiko ^a   Takebayashi, Shigeo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Fibronectin; Immunohistochemistry; Invasion; Metastasis; Thyroid carcinoma

Indexed keywords

FIBRONECTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THYROID CARCINOMA;

ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; THYROID NEOPLASMS;

EID: 0032844951     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00259-1     Document Type: Article

References (29)

1. Yamada K.M., Weston J.A. Isolation of a major cell surface glycoprotein from fibroblasts. Proc. Natl. Acad. Sci. USA. 71:1974;3492-3496.
2. Jaffe E.A., Mosher D.F. Synthesis of fibronectin by cultured human endothelial cells. J. Exp. Med. 147:1979;1779-1791.
3. Chen L.B., Maitland N., Gallimore P.H., McDougall J.K. Detection of the large external transformation-sensitive protein on some epithelial cells. Exp. Cell Res. 106:1977;39-46.
4. Villiger B., Kelly D.G., Kuhn C., McDonald J.A. Human alveolar macrophage fibronectin: synthesis and ultrastructural localisation. Clin. Res. 28:1980;745A.
5. Olden K., Yamada K.M. Mechanism of the decrease in the major cell surface protein of chick embryo fibroblasts after transformation. Cell. 11:1997;957-969.
6. Smith H.S., Riggs J.L., Mosesson N.W. Production of fibronectin by human epithelial cells in culture. Cancer. Res. 39:1979;4138-4144.
7. Pearlstein E., Hynes R.O., Franks L.M., Hemmings V.J. Surface proteins and fibrinolytic activity of cultured mammalian cell. Cancer Res. 36:1976;1475-1479.
8. Vaheri A., Kurkinen M., Lehto V.P., Linder E., Timpl R. Co-distribution of pericellular matrix protein in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc. Natl. Acad. Sci. USA. 75:1978;4944-4948.
9. Hynes R.O., Yamada K.M. Fibronectin: multifunctional modular glycoproteins. J. Cell Biol. 95:1982;369-377.
10. D'ardenne A.J., McGee J.O'D. Fibronectin in disease. J. Pathol. 12:1984;235-351.
11. Mohri H. Fibronectin and integrin interactions. J. Invest. Med. 44:1996;429-441.
12. Christensen L., Nielsen M., Andersen J., Clemmensen I. Stromal fibronectin staining pattern and metastasizing ability of human breast carcinoma. Cancer Res. 48:1988;6227-6233.
13. Ryu S., Jimi S., Takebayashi S. Thyroid carcinoma distinctively expresses intracellular fibronectin in vivo. Cancer Lett. 121:1997;189-193.
14. Hermanek P., Sobin L.H. Classification of Malignant Tumours, in: P. Hermanek, L.H. Sobin (Eds.), fourth ed., International Union Against Cancer. Springer: New York, pp. 1987;33-35.
15. Hedinger C., Williams E.D., Sobin L.H. Histological typing of thyroid tumours. second ed :1988;World Health Organization, Geneva.
16. Takei H., Iino Y., Horiguchi J., Yokoe T. Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma. Oncology. 52:1995;106-111.
17. Korach S., Poupon M.F., Du Villard J.A., Becker M. Differential adhesiveness of rhabdomyosarcoma-derived cloned metastatic cell lines to vascular endothelial monolayers. Cancer Res. 46:1986;3624-3629.
18. Matsui S., Takahashi T., Oyanagi Y., Takahashi S., Boku S., Takahashi K. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma. J. Hepatol. 27:1997;843-853.
19. Liotta L.A. Tumor invasion and metastasis. Role of extracellular matrix. Cancer Res. 46:1986;1-7.
20. Liotta L.A., Rao C.N., Barsky S.H. Tumor invasion and the extracellular matrix. Lab. Invest. 49:1983;636-649.
21. Barsky S.H., Siegal G., Jannotta F., Liotta L.A. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab. Invest. 49:1983;140-147.
22. Barsky S.H., Rao C.N., Grotendorst G.R., Liotta L.A. Increased content of type V collagen in desmoplasia of human breast carcinoma. Am. J. Pathol. 108:1982;276-283.
23. Fidler I.J., Gersten D.M., Hart I.R. The biology of cancer invasion and metastasis. Adv. Cancer Res. 28:1978;149-157.
24. Kawahara E., Okada Y., Nakanishi I., Iwata K., Kojima S., Kumagai S. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn. J. Cancer Res. 84:1993;409-418.
25. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 309:1984;30-33.
26. Ruoslahti E., Pierschbacher M.D. Arg-Gly-Asp: a versatile cell recognition signal. Cell. 44:1986;517-518.
27. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell. 60:1990;849-859.
28. Carcangiu M.L., Zampi G., Pupi A., Castagnoli A., Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 55:1985;508-528.
29. Ryu S., Jimi S., Eura Y., Kato T., Takebayashi S. Retention of intracellular fibronectin expression in original and metastatic thyroid carcinoma: an immunohistochemical study. Cancer Lett. 133:1998;215-222.